BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AltaRex Medical Corp. (ALXMF.PK): New Patents Expand Coverage For Cancer Therapeutics Portfolio


10/19/2005 5:11:25 PM

AltaRex Medical Corp. (TSX: ALT) ("AltaRex") and its strategic partner United Therapeutics (NASDAQ: UTHR) ("United") are pleased to announce that the U.S. patent office has issued a patent covering the use and composition of antibodies that target a specific sequence on the MUC-1 antigen, a cell-bound and secreted protein. The protein is commonly associated with breast, lung, ovarian and multiple myeloma cancers. Phase I clinical trials have already been completed with BrevaRex(R) MAb which forms immune complexes with circulating MUC-1 to stimulate an immune response to fight cancer. The fundamental technology was developed in collaboration with University of Maryland Baltimore.

Read at CCNMatthews

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES